Latest News and Press Releases

Oversubscribed financing led by Frazier Life Sciences with participation from F-Prime, Qiming Venture Partners, SR One and founding investors Cambridge Innovation Capital and Cambridge Enterprise...

Progress on share buyback programme ING announced today that, as part of our €1.1 billion share buyback programme announced on 30 October 2025, in total 2,190,349 shares were repurchased during the...

CGTN published an article exploring Xiongan New Area's transformation into a modern urban model, highlighting the success of orderly relocation of Beijing's non-capital functions as the core driver....

Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...

Idorsia nominates three Board Directors with outstanding pharmaceutical industry, management and financial expertise for election at the Annual General Meeting 2026 on May 6, 2026All Board members –...

Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid Approval in moderate-to-severe patients was based on pivotal study results...

First approved treatment in Japan for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS)Approval is based on positive Phase III data from multinational and Japanese studies in patients...

Press Release Weekly progress on share repurchase program to cover share plans and reduce capital Kaiseraugst (Switzerland), Maastricht (Netherlands), March 24, 2026 dsm-firmenich, innovators in...

Phonak AI-Powered Hearing Aids Recognized with 2026 Artificial Intelligence Excellence Awards

SAN FRANCISCO, March 24, 2026 (GLOBE NEWSWIRE) -- Accumulus Technologies hat heute die Einführung des Accumulus Connector („Connector“) bekannt gegeben. Die neue Plattformfunktion erweitert die...